3D printed drugs are drugs created by 3D printing technology that are used to treat patients suffering from dysphagia. 3D printed drugs have a porous structure that can rapidly disintegrate in the mouth. Aprecia Pharmaceuticals Companys SPRITAM levetiracetam is the first 3D printed drug, launched in the US in August 2015. Approved by the Food and Drug Administration (FDA).
Download Sample Report: https://www.alliedmarketresearch.com/request-sample/4508
Continuous technological developments in 3D printing techniques, rise in incidence of epilepsy and increasing awareness of 3D printing technology in developing countries are driving the market growth. However, lack of government regulations related to these drugs and adverse effects of 3D printed drugs are expected to limit the market growth.
Under the low growth scenario, the US is expected to hold the highest market share in 2020 and the market in the rest of North America is expected to grow at the highest rate, registering a CAGR of 5.1% till 2030.
Asia-Pacific is projected to grow at the highest growth rate during the analysis period due to rise in healthcare spending, increasing awareness related to 3D printing techniques, large patient population, and developments in healthcare infrastructure.
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/4508
Key Finding:
- In North America, the US is projected to dominate the market in 2020, while the rest of North America is projected to grow at the highest CAGR during the forecast period.
- Germany was a major player in the European 3D printed medicine market in 2016.
- Asia-Pacific will register the highest growth rate in the future.
- Australia is expected to grow at the highest CAGR in the Asia-Pacific 3D printed medicine market.
List of Key Players:
- Aprecia Pharmaceuticals,
- GlaxoSmithKline Plc.,
- Hewlett Packard Caribe,
- BV, LLC,
- 3D Printer Drug Machine
- FabRx Ltd.
𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
3D Printed Drugs Market: https://www.alliedmarketresearch.com/3d-printed-drugs-market
Plasma Fractionation Market: https://www.alliedmarketresearch.com/plasma-fractionation-market
𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com